Clinical effect of "Acess" for children on inflammation in gingiva of serious mentally and physically handicapped children and adults.
スポンサーリンク
概要
- 論文の詳細を見る
We use"ACESS"for children, the paste of Satou pharmaceutial Co., Inc., for serious mentally and physically handicapped children and adults having inflammation in gingiva, we observed the progress of every kind of clinical symptom, studied the improvement rate, and judged the effect of this paste.<BR>The results as follows.<BR>1) The efficacy rate of this paste was 92.1% (58 of 63 examples) at the forth week after we began to use this, and the last week 98.1% (62 of 63 examples) .<BR>2) The improvement rate of this paste showed 84.7% on redness, 90.7% on tumor, 88.1% on bleeding, 85.7% on pus discharge, 68.1% on smell of mouth four weeks later.<BR>3) On the efficacy of this paste, the improvement rate of the redness was 68.7% at the second week after we began to use this, the tumor was 92.2% in earlier.<BR>4) The oral smell and the smell of the institution was decreased than before this paste used.<BR>5) There was no special side-effect.<BR>As the result, "ACESS"for children was considered effective tooth paste for the gingivitis of seriously mental and physical handicapped children.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果